✦ LIBER ✦

Preclinical development of therapeutic biologics

✍ Scribed by Baumann, Andreas

Book ID: 120456420
Publisher: Informa plc
Year: 2008
Tongue: English
Weight: 153 KB
Volume: 3
Category: Article
ISSN: 1746-0441
DOI: 10.1517/17460441.3.3.289

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preclinical Cardiovascular Safety Evalua

Preclinical Cardiovascular Safety Evaluations of Biologics

✍ Hondeghem, Luc; Clerck, Fred 📂 Article 📅 2012 🏛 Springer International Publishing AG 🌐 English ⚖ 148 KB

Preclinical development of siRNA therape

Preclinical development of siRNA therapeutics for AL amyloidosis

✍ Ward, J E; Soo Hoo, P; O'Hara, C J; Connors, L H; Hovey, B M; Seldin, D C 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 512 KB

Preclinical evaluation of the immunologi

Preclinical evaluation of the immunological safety of biologics

✍ Jacques Descotes 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 42 KB

NIH TRND program: successes in preclinic

NIH TRND program: successes in preclinical therapeutic development

✍ McKew, John C.; Pilon, Andre M. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Preclinical Development Handbook || Safe

Preclinical Development Handbook || Safety Assessment of Biotechnology-Derived Therapeutics

✍ Gad, Shayne Cox 📂 Article 📅 2008 🏛 John Wiley & Sons, Inc. 🌐 English ⚖ 245 KB

A clear, straightforward resource to guide you through preclinical drug development Following this book's step-by-step guidance, you can successfully initiate and complete critical phases of preclinical drug development. The book serves as a basic,comprehensive reference to prioritizing and optimiz

Scientific review and recommendations on

Scientific review and recommendations on preclinical cardiovascular safety evaluation of biologics

✍ Hugo M. Vargas; Alan S. Bass; Alexander Breidenbach; Hal S. Feldman; Gary A. Gin 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 190 KB